Alexander C Klimowicz Selected Research

Alexander C Klimowicz Research Topics

Disease

19	Neoplasms (Cancer) 01/2018 - 03/2009
7	Squamous Cell Carcinoma of Head and Neck 05/2015 - 02/2011
5	Breast Neoplasms (Breast Cancer) 12/2016 - 04/2010
5	Neoplasm Metastasis (Metastasis) 10/2013 - 04/2011
3	Inflammation (Inflammations) 01/2021 - 09/2011
3	Nasopharyngeal Carcinoma 01/2016 - 04/2013
3	Multiple Myeloma 12/2011 - 04/2011
2	Head and Neck Neoplasms (Head and Neck Cancer) 03/2015 - 07/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2013 - 11/2010
1	Allergic Rhinitis 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Food Hypersensitivity (Food Allergy) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Colitis 01/2019
1	Ulcerative Colitis 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 06/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2013
1	Carcinoma (Carcinomatosis) 02/2013
1	Lymphatic Metastasis 10/2012
1	Hypoxia (Hypoxemia) 07/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2012
1	Glioma (Gliomas) 04/2011
1	Infections 04/2010

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2009
6	LigandsIBA 01/2019 - 07/2011
5	Formaldehyde (Formol)FDA Link 01/2018 - 01/2012
5	ParaffinIBA 01/2018 - 01/2012
4	Messenger RNA (mRNA)IBA 10/2012 - 11/2010
3	Tamoxifen FDA LinkGeneric 12/2016 - 04/2010
3	Biomarkers (Surrogate Marker)IBA 01/2016 - 10/2013
3	Cisplatin (Platino)FDA LinkGeneric 06/2013 - 02/2011
2	AntibodiesIBA 01/2019 - 02/2013
2	Estrogen ReceptorsIBA 01/2016 - 04/2010
2	Tyrosine (L-Tyrosine)FDA Link 10/2012 - 06/2011
2	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2012 - 06/2011
1	AllergensIBA 01/2021
1	CytokinesIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	Collagen Type VIIBA 01/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	Neutralizing AntibodiesIBA 01/2019
1	InterleukinsIBA 01/2019
1	CollagenIBA 01/2019
1	MutL Protein Homolog 1IBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 06/2017
1	Epidermal Growth Factor (EGF)IBA 12/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2016
1	Thymidylate SynthaseIBA 01/2016
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2016
1	N-formyl-13-dihydrocarminomycin (NFD)IBA 05/2015
1	Hematoxylin (Haematoxylon)IBA 03/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2015
1	VimentinIBA 10/2014
1	CateninsIBA 10/2014
1	Cadherins (E-Cadherin)IBA 10/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2013
1	Vascular Endothelial Growth Factor BIBA 06/2013
1	Hemoglobins (Hemoglobin)IBA 03/2013
1	STAT5 Transcription FactorIBA 10/2012
1	Oxygen (Dioxygen)IBA 07/2012
1	Carbonic Anhydrase IXIBA 07/2012
1	ErbB Receptors (EGF Receptor)IBA 01/2012
1	epidermal growth factor receptor VIIIIBA 01/2012
1	Polo-Like Kinase 1IBA 12/2011
1	Linoleic Acid (Linoleate)IBA 09/2011
1	LipopeptidesIBA 09/2011
1	Chemokine ReceptorsIBA 07/2011
1	IntegrinsIBA 06/2011
1	Estrogen Receptor alphaIBA 04/2010
1	Insulin-Like Growth Factor Binding Protein 5IBA 04/2010
1	Small Interfering RNA (siRNA)IBA 04/2010
1	3,3',4,5'-tetrahydroxystilbeneIBA 03/2009

Therapy/Procedure

9	Therapeutics 01/2018 - 04/2010
5	Radiotherapy 05/2015 - 11/2010
1	Injections 01/2019
1	Cystectomy 06/2013